For regulatory context on light-based therapies, see the FDAs overview of light therapy devices
Supplementary information ESM 1 (download DOCX (DOCX 1210 kb) Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Plasma and renal levels of MG and renal levels of MG-induced advanced glycation end products were higher in SHR than WKY rats 101
Y., & Lew, B
Technological Additives: Hydroxypropyl Methylcellulose: 169,039 mg/kg
(4) The peptide was suggested to significantly lower ROS levels, unlike higher concentrations that did not demonstrate similar protective actions